Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07081698 · ClinicalTrials.gov registry record · NA
Walnuts as an Infant Solid Food for Health
A NA study of Infant Development and Gut -Microbiota, sponsored by Colorado State University.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT07081698: Recruiting NA study of Infant Development and Gut -Microbiota, sponsored by Colorado State University.
NCT07081698 is a NA study of Infant Development and Gut -Microbiota that is actively recruiting participants, run by Colorado State University. The registered enrollment target is 90 participants, below the 400-participant average among 30 other Infant Development trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07081698, a NA study of Infant Development and Gut -Microbiota, is actively recruiting participants, sponsored by Colorado State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective is to investigate the effect of walnuts on gut microbiota, inflammatory markers, atopic dermatitis status, and indices of allergy outcomes in breastfed infants during early complementary feeding. The three primary aims include: Aim 1: Evaluate the effect of walnut consumption on gut microbiota structure and function, inflammation, atopic dermatitis, and allergy outcomes. Aim 2: Evaluate the impact of walnut consumption on infant growth trajectories and risk of overweight. Aim 3 (exploratory): Identify walnut-specific food signatures that are associated with gut microbiota and immunity biomarkers using a novel nutri-metabolomics technique.
Primary Outcome
16S rRNA amplicon sequencing is used to profile taxonomic makeup of fecal specimens. Within the gut microbiome composition, microbial diversity will be summarized using common ecological measures (Good's coverage, Sobs, and Shannon alpha diversity).
Conditions Studied
Interventions
- OTHER Infant walnut intake
Study Locations (1)
Colorado
- Food Science and Human Nutrition Clinical Research Laboratory - Fort Collins
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-05-18 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07081698 shows while recruiting
NCT07081698 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 400-participant average among 30 other Infant Development trials with a reported enrollment target (77% lower).
The record links to 3 conditions, with Infant Development appearing as the primary indexed condition, and to 1 intervention - of which Infant walnut intake is the first listed.
NCT07081698 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07081698 about?
NCT07081698 is a clinical study titled "Walnuts as an Infant Solid Food for Health". The objective is to investigate the effect of walnuts on gut microbiota, inflammatory markers, atopic dermatitis status, and indices of allergy outcomes in breastfed infants during early complementary feeding. The three primary aims include: Aim 1: Evaluate the effect of walnut consumption on gut ...
What is the current status of trial NCT07081698?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-05-18. Estimated completion is 2027-12-31.
What conditions does trial NCT07081698 study?
This clinical trial studies the following conditions: Infant Development, Gut -Microbiota, Inflammatory Markers.
What interventions are being tested in trial NCT07081698?
The interventions under investigation include: Infant walnut intake (OTHER).
Who is sponsoring clinical trial NCT07081698?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07081698 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infant Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07081698's enrollment target sits among peer trials
90 20th of 30 higher than 11 of 30 other Infant Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
The Impact of Music Medicine on Preterm Brain Development and Behavior
RECRUITING · NA
-
Intervening With Opioid-Dependent MothersMothers and Infants
RECRUITING · NA
-
Investigating Baby Behavior and Family Technology Use Study
RECRUITING · NA
-
Investigating Fit and Satisfaction of the Prone Positioner
RECRUITING · NA
-
Talk With Me Baby to Enhance the Early Home Language Environment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI